medline.ch Onkologie Urologische Tumoren

	Early Detection of Prostate Cancer: Advances in Screening, Biomarkers, and Imaging Strategies. Curr Oncol Rep Anya O, Chikere O, Breen P, Oletu H, Asoluka P, Sokolova A. PMID: 42944960 [PubMed - indexed for MEDLINE]
	Perioperative outcomes of intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy in multicenter KORARC database. World J Urol Yuk HD, Han JH, Jeong SH, Jeong CW, Kwak C, Oh JJ, Kwon TG, Kim TH, Jeon SH, Lee SH, Nam JK, Kim WS, Jeong BC, Lee JY, Hong SH, Han WK, Ham WS, Lee YG, Lee YS, Park SY, Yoon YE, Kang SG, Kang SH, Ku JH, Korean Robot Assisted Radical Cystectomy (KORARC) Study Group. PMID: 42944928 [PubMed - indexed for MEDLINE]
	Longitudinal changes in renal function and renal parenchymal width in patients with malignant ureteral obstruction managed with ureteral stents. World J Urol Huang Q, Huang Y, Han B, Lian X, Huang Z, Wang T, Chen B, Chen Y. PMID: 42944758 [PubMed - indexed for MEDLINE]
	Nephron-Sparing Strategies for Tumor-Bearing Horseshoe Kidney: From Surgeries to Pharmaceuticals. Pharmaceuticals (Basel) He MZ, Zhou H. PMID: 42943357 [PubMed]
	FGFR 1-3 Alteration Frequency in Muscle-Invasive Urothelial Bladder Cancer and Its Effect on Prognosis. Medicina (Kaunas) Ça, Gökta, Somuncu MN, K, Koçak MZ, Hendem E, Y, Gürbüz AF, Canlar H, U, Ery, Artaç M, Araz M. PMID: 42942557 [PubMed - indexed for MEDLINE]
	Early Dynamic (18)F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study. Medicina (Kaunas) Saylam B, Temelli B, Nebio, Efesoy O, Bozlu M. PMID: 42942552 [PubMed - indexed for MEDLINE]
	Integrative Molecular Profiling and Single-Cell Characterization of LHFPL5 Reveal Cancer-Specific Regulatory Features in Clear Cell Renal Cell Carcinoma and Lung Adenocarcinoma. Medicina (Kaunas) Al-Nakhle HH, Doha ZO. PMID: 42942502 [PubMed - indexed for MEDLINE]
	CPTAC Consensus Subtypes Add No Incremental Prognostic Value Beyond Stage and Grade in Clear Cell Renal Cell Carcinoma: A Proteomic Reanalysis. Life (Basel) Yasar S, Yagin FH, Alzakari SA, Alkhalifa AK, Al-Hashem F, Tabnjh AK. PMID: 42942338 [PubMed]
	Dosimetric Validation of Ethos Online Adaptive Radiotherapy for Prostate Cancer: An End-to-End Phantom Study. Life (Basel) Janiszewska M, Raczkowski M. PMID: 42942278 [PubMed]
	Multimodal Evaluation of [(225)Ac]Ac-PSMA-617 Therapy in mCRPC: PET Based Total Tumor Volume, PSA Kinetics, and Blood Biomarkers. Int J Mol Sci Ebrahimifard A, Bagheri S, Wang Q, Hojjat Shamami A, Di Fazio P, Eilsberger F, Müller L, Luster M, Librizzi D, Hooshyar Yousefi B. PMID: 42942097 [PubMed - indexed for MEDLINE]
	Special Issue: Prostate Cancer Research Update: Molecular Diagnostic Biomarkers. Int J Mol Sci Baryshev M. PMID: 42942079 [PubMed - indexed for MEDLINE]
	Rapidly Progressive Dedifferentiated Liposarcoma of the Spermatic Cord: A Case Report. Int J Mol Sci Rocha F, Figueroa-Emiliani J, Vargas-Castellanos E. PMID: 42941942 [PubMed - indexed for MEDLINE]
	Potential Molecular Links Between Triclosan Exposure and Prostate Cancer: An Integrative Computational Analysis. Int J Mol Sci You H, Zou Y, Liu J, Xiao Y, Li J, Xu J, Xu W. PMID: 42941926 [PubMed - indexed for MEDLINE]
	G Protein-Coupled Receptors in Prostate Cancer: Pathophysiological Implications and Potential for Innovative Therapeutics. Int J Mol Sci Sarmento-Cabral A, Herrero-Aguayo V, Sáez-Martínez P, Alors-Pérez E, León-González AJ, López-Cánovas JL, Montero-Hidalgo AJ, Gahete MD, Jiménez-Vacas JM, Luque RM. PMID: 42941869 [PubMed - indexed for MEDLINE]
	Urinary Metabolomics in Bladder Cancer: A Scoping Review of Current Evidence and Translation Implications. Int J Mol Sci Carapito Â, Amaro F, Roque AC, Carvalho F, Pinto J, Guedes de Pinho P. PMID: 42941758 [PubMed - indexed for MEDLINE]
	Current State of Adjuvant Hormone Therapy in Prostate Cancer and in the Management of Pelvic Nodal Recurrence: A Narrative Review. J Clin Med D'Andrea B, Montagna A, Benevento I, Rago L, Metallo V, Morano G, Romaniello M, Possidente F, De Fina V, Bianculli A, Lerose RMC, Mazzoccoli C, Telesca D, Storto G, Gallicchio R, Lazzari G. PMID: 42941560 [PubMed]
	Real-World PSA Response and Safety Outcomes of 177Lu-PSMA-617 in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Validation Study. J Clin Med Choi JH, Kim CG, Oh KT, Heo JE, Lee J, Jang WS, Lee SH, Choi YD, Beom SH, Kang WJ, Han WK, Han H. PMID: 42941282 [PubMed]
	VGLL4 Suppresses Malignant Phenotypes of Clear Cell Renal Cell Carcinoma Cells Through Modulation of Hippo/YAP and Wnt/Î²-Catenin Signaling Pathways. Biomedicines Zhang Y, Wang S, Zhao Z, Yuan T, Zhu C, Zhong L. PMID: 42940140 [PubMed]
	Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression. Biomedicines Yuan J, Zhan P, Liu J, Lu G, Wang H, Xiao M, Li D. PMID: 42940099 [PubMed]
	Aptamers as Innovative Tools for Prostate Cancer: Tumor Recognition and Biological Activity. Biomolecules Sassaro TF, Ferreira DDP, Moreira ADS, Abreu RDS, de Araújo NS, Bastos NC, Fernandes PV, Degrave WMS, Waghabi MC. PMID: 42939667 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 182515

Seite 1 von 9126

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung